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Abstract
Release of cell surface-bound ligands by A-Disintegrin-And-Metalloprotease (ADAM) transmembrane metalloproteases is
essential for signalling by cytokine, cell adhesion, and tyrosine kinase receptors. For Eph receptor ligands, it provides the
switch between cell-cell adhesion and repulsion. Ligand shedding is tightly controlled by intrinsic tyrosine kinase activity,
which for Eph receptors relies on the release of an inhibitory interaction of the cytoplasmic juxtamembrane segment with
the kinase domain. However, a mechanism linking kinase and sheddase activities had remained elusive. We demonstrate
that it is a membrane-proximal localisation of the latent kinase domain that prevents ephrin ligand shedding in trans.
Fluorescence lifetime imaging microscopy and electron tomography reveal that activation extends the Eph receptor
tyrosine kinase intracellular domain away from the cell membrane into a conformation that facilitates productive
association with ADAM10. Accordingly, EphA3 mutants with constitutively-released kinase domains efficiently support
shedding, even when their kinase is disabled. Our data suggest that this phosphorylation-activated conformational switch
of EphA3 directly controls ADAM-mediated shedding.
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Introduction
The ADAM (A-Disintegrin-And-Metalloprotease) trans-
membrane proteases fulfil essential functions during normal
and pathological tissue- and organ-development [1]. ADAM10
and 17 in particular are widely expressed and knock-out mice
lacking expression of either gene show severe, lethal defects in
early development, in the formation of somites and the central
nervous system (ADAM10) and the cardiovascular system
(ADAM10/17). They have important roles in receptor tyrosine
kinase (RTK) and Notch signalling, highlighted by phenotypic
resemblance of ADAM 10/17 knockouts with those of Notch,
the epidermal growth factor receptor (EGFR) and EGFR
ligands [2,3,4,5]. ADAM10 and 17 both target a range of
EGFR ligands with distinct specificities [6], while ADAM10
cleaves both Notch and its ligand delta, as well as other targets
with prominent roles in disease including amyloid precursor
protein, interleukin 6 receptor [5], cadherins [7], and ligands
for Eph RTKs (Ephs) [8,9].
Ephs and their membrane bound ligands (ephrins) control cell
positioning during normal and oncogenic development by
modulating cell-cell adhesion and cell-cell segregation or repulsion
[10]. Similar to ADAMs, they function in developmental processes
including somite formation, neural and cardiovascular develop-
ment [11,12], which, together with their common expression
patterns, supports functional evidence for the critical role of
ADAM10 in Eph biology [8,9]. Eph function relies on the direct
contact between Eph- and ephrin-expressing cells, which triggers
the assembly of signalling clusters at the cell-cell interface [13] and
initiates Eph ‘‘forward’’ and ephrin ‘‘reversed’’ signals into the
respective cells [10]. For repulsion to proceed it is essential that the
multivalent [14,15] signalling complexes that tether Eph- and
ephrin-expressing cells are disrupted, allowing the cells to retract
via ensuing actin cytoskeletal rearrangement [16]. In the case of
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ephrin-shedding by ADAM10, constitutively associated with Ephs
on the opposing cell [9], is required for repulsion to occur [8,9].
ADAM proteins are produced as inactive precursors that
become catalytically active upon removal of the prodomain during
secretion. Interestingly, there is little evidence for a substrate
cleavage sequence motif, and the regulation of proteolytic
specificity is achieved by interaction of substrates with the non-
catalytic disintegrin and cysteine-rich extracellular ADAM do-
mains. For ephrin cleavage, a substrate recognition module within
the cysteine-rich domain of ADAM10 specifically binds only the
high-affinity ligand-receptor complex to ensure that only Eph
receptor-bound ephrins are cleaved [9].
n addition to this direct control of ADAM10-facilitated
shedding, substantial evidence documents intracellular regulation
of ADAM proteases [4,5]. ADAM activity is enhanced upon
activation of (receptor) tyrosine kinase signalling by growth factors,
phorbol esters, or phosphatase inhibitors, while tyrosine kinase
inhibitors or dominant-negative RTK mutants attenuate ADAM
activity [4]. This protein kinase-controlled ADAM activity is an
essential component of the autocrine, mitogenic signalling that is
triggered by G-protein coupled [17,18] or stress-induced EGF
receptor transactivation [17,19]. Conversely, ADAM shedding of
L-selectin during leukocyte trafficking [20] is blocked by
Calmodulin (CaM), via its binding to the 17-residue L-selectin
intracellular domain (ICD), while CaM inhibitors trigger shedding
of the L-selectin ectodomain [21]. Surprisingly, while ADAM
family members harbour potential protein docking motifs [4],
cytoplasmic-truncated ADAM17 is fully functional [22], and
signalling mechanisms regulating ADAM activity have remained
elusive.
To elaborate the intracellular regulation of ADAMs by RTK
signalling we investigated ADAM10 catalysed ephrin-A5 cleavage
that is mediated by EphA3-expressing cells, as previous studies
demonstrated that this sheddase activity depends on ephrins
binding and activating the EphA3 RTK [8,9]. Our results suggest
that a conformational change in the EphA3 ICD, which upon
activation moves the kinase domain away from the plasma
membrane, relieves a steric hindrance preventing productive
association with ADAM10. We demonstrate that this loss of steric
hindrance, resulting from extension of the active Eph ICD, rather
than classical signalling via intermediate proteins, regulates the
sheddase activity of ADAM10.
Results
Intracellular Regulation of ADAM10-Mediated Ephrin
Cleavage
Eph activation, phosphorylation, and signalling relies on the
assembly of multimeric Eph/ephrin complexes [11,12]. For in vitro
experiments, recombinant proteins comprising two ephrin extra-
cellular domains fused onto the Fc portion of human IgG (ephrin-
Fc) can be clustered with anti-Fc antibodies to elicit Eph activation
[23,24,25]. We tested the cleavage of clustered or non-clustered
ephrin-A5-Fc by cell surface ADAM10 in cultures of HEK293T
(transformed human embryonic kidney cells) cells expressing either
wild type (Wt) EphA3 or mutant, kinase-inactive EphA3[K653M].
Immunoblot analysis confirmed that the release of ephrin-A5 from
the Fc complexes was dependent on pre-clustering and indeed was
greatly reduced in cultures of cells expressing the kinase-inactive
EphA3 mutant (Figure 1A, Figure S1A).
Surprisingly, however, co-immunoprecipitation analysis re-
vealed robust binding of ADAM10 to an EphA3 mutant lacking
the whole ICD (EphA3[DICD], Figure S1B). This implies that the
ADAM10/EphA3 association, which is necessary for ephrin
cleavage and involves constitutive as well as ephrin-augmented
interactions of their extracellular domains [8,9], does not require
the contribution of the EphA3 ICD. We therefore assessed if
cytoplasmic-truncated ADAM10[DICD] or EphA3[DICD] could
catalyse cleavage of Alexa-labelled ephrin-A5-Fc that had been
conjugated to Protein-A-coated Dynabeads, an experimental
approach previously used to characterise ephrin shedding by
ADAM10 [9]. In agreement with earlier studies [8], over-
expression of non-functional ADAM10 lacking the MP domain
(ADAM10DMP) acts as a dominant negative protein to effectively
prevent ephrin shedding (Figure 1B). By contrast, over-expression
of cytoplasmic-truncated ADAM10
[DICD] did not notably affect ephrin-A5 cleavage and internal-
isation (Figure 1B), indicating that the ADAM ICD may not be
required for its sheddase activity [22].
Likewise, cells over-expressing EphA3[DICD] efficiently sup-
ported ephrin-A5 shedding from Dynabeads, as evident from the
marked cell surface labelling with fluorescent ephrin that had been
released from the beads (Figure 1C). The lack of efficient
internalisation of the cleaved ephrin-A5 into cells in this case
suggested that the EphA3 ICD is required for internalisation of the
ligand/receptor complex, but is not essential for ligand cleavage.
Cell surface labelling was efficiently blocked by ADAM metallo-
protease inhibitors (Figure S2), consistent with ADAM-dependent
shedding of ephrin-A5 [9].
Author Summary
The Eph transmembrane receptors are part of the receptor
tyrosine kinase family and play important roles in
communication between neighbouring cells. An Eph
receptor binds to its ligand, membrane-tethered ephrin,
on a neighbouring cell so as to form a stable complex and
activate downstream signalling events. One such event is
regulation of ADAM10, a transmembrane protease of the
ADAM metalloprotease family, which provides a feedback
mechanism to Eph signalling. ADAM10 is located on Eph-
expressing cells and cleaves ephrin from its membrane
tether on the opposite cell (through its so-called sheddase
activity), thereby separating the cell-cell connection and
allowing the signalling complex to internalise. In other
biological contexts, activity of the ADAM metalloprotease
family underlies signalling mechanisms such as oncogenic
EGF-receptor transactivation, adhesion molecule shedding
and cytokine/chemokine release. In general, ADAM func-
tion is enhanced when receptor tyrosine signalling is active
and repressed when tyrosine kinase signalling is inhibited.
However, the mechanism through which receptor tyrosine
kinase signalling regulates ADAM10, have remained
elusive. By combining fluorescence lifetime imaging
microscopy (FLIM) and electron microscopic tomography
of EphA3, we have demonstrated in live cells at molecular
resolution that tyrosine phosphorylation of activated
EphA3 triggers a measurable movement of the kinase
domain away from the plasma membrane. Only this
conformation of the EphA3 kinase domain away from
the plasma membrane permits ADAM10 to come close
enough to EphA3 so that it can reach its tightly EphA3-
bound substrate, ephrin-A5. Our findings delineate a new
regulatory concept in cell-cell communication, whereby
control over proteolytic sheddase activity is provided by
an activation-induced switch in the conformation of the
cytoplasmic domain of a receptor tyrosine kinase, rather
than by a cytosolic signalling pathway.
Eph-Controlled Ephrin Shedding
PLoS Biology | www.plosbiology.org 2 October 2009 | Volume 7 | Issue 10 | e1000215Figure 1. Ephrin shedding is inhibited by lack of kinase activity but not by cytoplasmic truncation of EphA3 or ADAM10. (A) EphA3
kinase activity is required for effective ephrin cleavage. HEK293T cells expressing EphA3 Wt or EphA3[KM] (with a mutated ATP-binding site, K653RM)
were treated with clustered (C) or non-clustered (NC) ephrin-A5-Fc. Cleaved ephrin-A5 was extracted by EphA3-Fc pulldown and recovered ephrin-A5
and total cell extracts were immunoblotted as indicated. Low level ephrin-A5 shedding observed with ephrin-A5-Fc -treated EphA3[KM] cells is likely
due to endogenous EphA3 present in parental HEK293T cells [45]. (B) Truncation of the ADAM10 ICD (DICD) does not affect ephrin-A5 cleavage and
internalisation. Cells expressing endogenous ADAM10 and EphA3-GFP were transfected with HA-ADAM10[DMP] (top), HA-ADAM10[DICD] (middle),
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Correlates with ADAM10-Mediated Ephrin Cleavage
To reconcile the observations that ephrin cleavage requires Eph
kinase activity but still occurs in the absence of the entire ICD, we
considered recent studies demonstrating an activation- and
phosphorylation-dependent release of the Eph juxtamembrane
(JM) segment from an inhibitory interaction with the kinase
domain [26]. The existence of this structural switch, which
converts a static/constrained conformation of the JM domain into
a dynamic/relaxed one [26,27], was recently confirmed also for
EphA3 [28].
We hypothesized that the inactive/constrained JM segment
positions the kinase domain close to the membrane, a configura-
tion that imparts a steric obstruction to the productive ADAM10/
EphA3 interaction and thereby controls ephrin shedding. To test
this hypothesis we examined whether forced approximation of the
EphA3 kinase domain to the plasma membrane affects ADAM10
association and function. For these experiments we designed a
series of EphA3 mutants (Figure 2A) including: i) ‘‘EphA3[DJX]’’
short (‘‘S’’), lacking JM residues 591–614 and replicating the
previously-reported EphB2[D599–621] [26]; ii) ‘‘EphA3[DJX]’’
long (‘‘L’’) lacking all JM residues 567–614; iii) ‘‘EphA3[2YE]’’
or control vector (bottom) and exposed to Alexa
594ephrin-A5-Fc coated beads. EphA3-GFP, internalised ephrin-A5, and HA-ADAM staining (Alexa
647)
were imaged by confocal microscopy. The relative ephrin-A5 labelling of receptor-expressing cells (mean+/2SEM), with or without ADAM10[DICD] or
ADAM10[DMP] co-expression, is shown. (C) Cleavage of ephrin-A5 from conjugated beads in the presence of EphA3[Dcyto]-expressing cells. HEK293T
cells expressing Wt EphA3-GFP or EphA3[Dcyto] as indicated were incubated with Alexa
594ephrin-A5-Fc-conjugated beads before staining with
Alexa
647anti-EphA3 antibody. Confocal microscope images show representative cells stained with cleaved ephrin-A5. Pseudocolours in the merged
images illustrate: green, EphA3-GFP; red, Alexa
594ephrin-A5; blue, Alexa647anti-EphA3 antibody. The graph shows the relative ephrin-labelling of cells
(mean+/2SEM), with cells containing internalised ephrin shown in dark grey and cell-surface ephrin in light gray.
doi:10.1371/journal.pbio.1000215.g001
Figure 2. Mutation of the JM domain affects EphA3 phosphorylation and ADAM10 association. (A) Schematic structure of Wt EphA3-GFP
andderived ICDmutants (see textfordetails)that were usedin these studies. Y,tyrosine;P,phospho-tyrosine;E,glutamate (pseudophosphorylation) ; X,
inactive kinase. (B) Tyrosine phosphorylation of Wt and mutant EphA3. EphA3 immunoprecipitates from lysates of ephrin-A5-Fc-stimulated cells were
immunoblotted with anti-phosphotyrosine and anti-EphA3 antibodies as indicated. (C) ADAM10 association with Wt and mutant EphA3. ADAM10
immunoprecipitates and total cell lysates from Wt or mutant (as indicated) EphA3-transfected cells (ephrin-A5-treated) were analysed for EphA3 and
ADAM10 by immunoblot (see Figure S4B). The average ratio (+/2SD) of EphA3 in precipitates relative to lysates (n=2 experiments) is plotted, with
EphA3[2YE] as internal reference.
doi:10.1371/journal.pbio.1000215.g002
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domain [26]; and iv) EphA3[2YE-KM], a kinase-inactive form of
EphA3[2YE]. All mutants were expressed at the cell surface and
functional in ephrin-A5 binding (Figure S3). Loss of the JM
tyrosines Y596 and Y602 in the truncated (EphA3[DJXS]) or
YRE substituted (EphA3[2YE]) JM domain reduced ephrin-A5
induced phosphorylation (Figure 2B) without loss of EphA3 kinase
activity (Figure S4A). By contrast, only marginal phosphorylation
of EphA3[DJXL] (Figure 2B) suggests that the very close proximity
of the kinase domain to the inner membrane leaflet impedes the
substrate interaction for this mutant.
Importantly, all EphA3 mutants retained the capacity to
associate and co-immunoprecipitate with ADAM10 (Figure 2C,
Figure S4B), in agreement with our previous finding that ADAM
interacts with EphA3 via specific regions in their extracellular
protein domains [9]. However, compared to Wt EphA3 or
EphA3-[2YE], binding of the [DJXS] and [DJXL] mutants to
ADAM10 was notably reduced, supporting our hypothesis that
approximation of the EphA3 kinase domain to the plasma
membrane imparts steric obstruction to ADAM10 binding that
is relieved during JM domain unfolding. Also, binding to
ADAM10 of ‘‘kinase-dead’’ [2YE-KM] was reduced compared
to EphA3-[2YE] (Figure 2C), suggesting either that Eph kinase
activity may play a role in facilitating the ADAM10 interaction or
that JM domain unfolding of the [2YE-KM] mutant is incomplete,
as implied from the crystal structure [27].
To test our hypothesis of a conformational switch in the EphA3
JM domain that controls ADAM10 access and ephrin shedding,
we compared the ability of Wt and mutant EphA3 receptors to
support ADAM-catalysed shedding from ephrin-A5-coated beads
and internalisation into EphA3-expressing cells. Confocal micros-
copy confirmed that indeed both EphA3 JM-truncations signifi-
cantly affected the capacity to promote ephrin-A5 shedding,
whereas the [2YE] mutant behaved comparable to Wt EphA3
(Figure 3A, 3B). Interestingly, kinase-compromised EphA3[2YE-
KM] with an unfolded JM domain behaved similar to cytoplas-
mic-truncated EphA3[DICD] (Figure 1C): cell surface ephrin-
staining away from the beads revealed ability of this mutant to
support ephrin shedding but failure to internalise the shed ligand
(Figures 3A, 3B and S5A), also evident when soluble, pre-clustered
Alexa
594ephrin-A5-Fc was used as substrate (Figure S5B). Since
EphA3[2YE] bearing an intact kinase but lacking JM tyrosines is
internalised normally, this argues for EphA3 endocytosis requiring
tyrosine kinase activity and/or phosphorylation, likely of the
remaining critical phosphorylation site within the Eph kinase
activation-loop [13]. We confirmed the ability to support ephrin-
shedding using immunoprecipitation analysis, revealing similar
levels of cleaved ephrin-A5 in cultures of EphA3[2YE] and
EphA3[2YE-KM] cells (Figure 3C).
These experiments indicate that it is the proximity of the EphA3
kinase domain to the plasma membrane rather than its kinase
activity per se that determines if shedding by ADAM10 is inhibited
or promoted. For further evidence, and to clarify if there is any
contribution from signalling intermediates that may communicate
between the Eph and ADAM cytoplasmic domains, as implied from
previous studies [4,5], we compared ephrin-A5 shedding by cells
co-expressing EphA3 mutants together with either Wt ADAM10 or
with cytoplasmic-truncated ADAM10[DICD] (Figures 3D and
S6B). ADAM10[DICD] would be expected to overcome the steric
hindrance exerted by EphA3 JM mutants, compared to full length
ADAM10. To avoid the potential ambiguity caused by the presence
of endogenous, Wt ADAM10/EphA3 complexes, we performed
these experiments in mouse embryonic fibroblasts (MEFs) from
ADAM10 KO mice [2] lacking any detectable ADAM10
expression (Figure S6A). Similar to our findings in HEK293T cells,
ephrin-A5 shedding in these MEFs was apparent upon co-
expression of either Wt or [DICD] ADAM10 together with Wt
EphA3, and was greatly reduced when either of the EphA3 JM
mutants EphA3[DJXL] or EphA3[DJXS] were expressed with Wt
ADAM10. Importantly, co-expression of cytoplasmic-truncated
ADAM10[DICD] together with EphA3[DJXL] or EphA3[DJXS]
‘‘rescued’’ the inhibitory effect of the JM positioning of the Eph
kinase domain and resulted in shedding comparable to that seen
with the Wt ADAM and Eph proteins (Figures 3D and S6B).
Together, these experiments demonstrate that ephrin-A5
shedding by ADAM10 is controlled by steric hindrance exerted
by the membrane-proximal EphA3 kinase domain, which prevents
the functional interaction with ADAM10 that is needed for
efficient substrate (ephrin) cleavage to occur.
Steric Hindrance as a Conserved Mechanism of ADAM
Regulation
In addition to controlling RTK function, ADAMs are key
modulators of cell–matrix interactions [29], and ADAM17-
catalysed exodomain shedding regulates the function of the
leukocyte adhesion protein L-selectin [20]. Of note, L-selectin
shedding is blocked by CaM binding to the L-selectin cytoplasmic
domain and is promoted by CaM inhibitors [21], indicating a
similar regulation by steric hindrance. Intriguingly, these inhibitors
also trigger metalloprotease-dependent EGFR signalling [30],
further suggesting that steric hindrance, in this case imparted by
CaM binding within the EGFR JM region [31], may promote
ADAM-catalysed ligand release.
To test the hypothesis that a bulky protein domain at the JM
position would impair a productive ADAM/EphA3 alignment, the
EphA3 cytoplasmic domain was replaced with that of L-selectin.
We surmised that CaM-loaded EphA3/L-selectin could not
effectively promote ephrin cleavage, while conversely inhibition
of CaM binding to this chimeric receptor using CaM inhibitors
should favour ADAM10 association and ephrin-A5 cleavage.
Control experiments confirmed inhibition of CaM binding (Figure
S7A) and increased ADAM10 association (Figure S7B). Indeed,
shedding from ephrin-A5-Fc coated beads was markedly higher
in inhibitor-treated than in untreated cells expressing EphA3/
L-selectin (Figure 4A, 4B). Furthermore, immunoblotting of
cleaved ephrinA5-Fc from cultures of EphA3/L-selectin cells
(Figure 4C) confirmed shedding in CaM-inhibitor-treated cells but
not in control cells, at levels that are comparable to those observed
in EphA3[2YE-KM] cell cultures (Figure 4C). Likewise, engineer-
ing of inactivating mutations into the CaM-binding domain [21]
(EphLsel EE) notably increased the capacity of these cells to
support ephrin shedding as compared to Wt EphA3-L-selectin
cells (Figure S7C). Of note, in these experiments ephrin-A5
labelled the cell membrane but was not internalised into cells with
EphA3/L-selectin, confirming the need for the intact EphA3
cytoplasmic domain for endocytosis. We confirmed CaM
inhibitor-induced shedding also of cell bound ephrin-A5, using
co-cultures of green-fluorescent protein (GFP)-ephrin-A5-express-
ing and EphA3/L-selectin-expressing cells (Figure S8A). In
agreement with these imaging experiments, immunoblotting of
cleaved GFP-ephrin-A5 recovered from GFP-ephrin-A5-express-
ing cells that had been co-cultured with EphA3/L-selectin-cells
revealed CaM inhibitor-induced shedding, which is absent in
inhibitor-treated control cells (Figure S8B). Thus, CaM binding to
the EphA3/L-selectin protein effectively regulates shedding of
ephrin-A5, further demonstrating that ADAM10 activity is
controlled by steric constraints in the JM region of a (chimeric)
Eph-Controlled Ephrin Shedding
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internalisation by cells expressing Wt EphA3 and EphA3 mutants illustrated in Figure 2A. Wt or mutant EphA3-GFP transfected cells (green) were
treated with Alexa
594ephrin-A5-coated beads (red) and imaged by confocal microscopy. Individual and merged images are illustrated. Yellow arrow
heads denote areas of sustained interactions between cell surface EphA3 and ephrin-A5 beads. White arrows indicate areas of distinct binding of
cleaved ephrin and lack of internalisation in EphA3[2YE-KM] cells. (B) The quantitated relative ephrin-A5-labelling of receptor-expressing cellsi s
represented, with internalised ephrin fluorescence shown in grey and cell surface ephrin-A5 in unfilled bars. Mean values (n=3 experiments, 30–100
cells each) are shown, with error bars indicating 95% confidence intervals determined by the ANOVA test for multiple comparisons. (C) Ephrin
cleavage by EphA3[2YE] is kinase independent. Ephrin-A5 shed from coated beads by cells expressing Wt or mutant EphA3-GFP, as indicated, was
recovered by pulldown with EphA3-Fc and immunoblotted with anti-ephrin-A5 (top) antibodies as in Figure 1A. The EphA3 level in cell lysates is also
shown (bottom). (D) Removal of the ADAM10 ICD reconstitutes ephrin shedding in cells expressing EphA3 JX mutants. ADAM102/2 MEFs
transfected with combinations of GFP-tagged EphA3 (Wt, DJXS or DJXL) and HA-tagged ADAM10 (Wt, DMP or DICD) were assayed for ephrin-A5
cleavage as in (A). The graph shows the mean ephrin staining of cells co-expressing the indicated constructs, with error bars indicating 95%
confidence intervals determined by ANOVA analysis.
doi:10.1371/journal.pbio.1000215.g003
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PLoS Biology | www.plosbiology.org 6 October 2009 | Volume 7 | Issue 10 | e1000215Figure 4. CaM-binding to chimeric EphA3/L-selectin regulates ephrin cleavage. (A) Confocal analysis of ephrin release: EphA3/L-selectin
transfected HEK293T cells were pre-treated with CaM inhibitors trifluoperazine dimaleate (TFP, 15 mM), Calm (2 mM), W7 (N-6-Aminohexyl0-5-chloro-
1-naphthalenesulfonamide, 50 or 100 mM), or vehicle control before incubation with Alexa
488ephrin-A5-Fc beads. Cell surface EphA3/L-selectin
(Alexa
647 a-EphA3 antibody, red) and Alexa
488ephrin-A5 (green) were imaged in fixed cells by confocal microscopy. Insets show cells treated with
100 mM W7. (B) The ratio of ephrin-A5-associated and EphA3/L-selectin associated fluorescence was estimated from images of control or inhibitor-
treated cell cultures taken under identical conditions. Mean values are illustrated (n.4), with error bars indicating 95% confidence intervals
Eph-Controlled Ephrin Shedding
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dependent signalling activity.
Activation of EphA3 Is Accompanied by Extension of the
ICD
To this point our analysis strongly argues for the notion that the
‘‘relaxed’’ and ‘‘constrained’’ conformations of active and inactive
EphA3, respectively, would direct functional or dysfunctional
alignment of ADAM10 with EphA3. To examine in intact cells, if
indeed activation uncoils the EphA3-kinase domain away from the
plasma membrane, we developed a Fo ¨rster resonance energy
transfer (FRET) imaging approach [32] that is sensitive to the
distance between the EphA3-COOH (C)-terminus and the plasma
membrane. Here, we used fluorescence lifetime imaging micros-
copy (FLIM) to monitor FRET between EphA3-GFP and the
inner membrane leaflet of Cos7 cells labelled with membrane-
targeted
tkRasRFP (red-fluorescent protein) (Figure 5A) [33].
Confocal FLIM analysis of live cells activated with clustered
ephrin-A5-Fc revealed that fluorescence lifetimes (t)o fc e l l -
surface EphA3-GFP increased (showing reduced FRET)
10–20 min after stimulation (Figure 5B, 5C and Figure S9A,
S9B), indicating a drop of the cytoplasmic domain from a
membrane-proximal to a membrane-distal conformation. The
receptor population with increased fluorescence lifetimes (acti-
vated EphA3) returned to pre-stimulation levels at 40 min, likely
reflecting de-phosphorylation of activated EphA3. However,
energy transfer from GFP (donor) to
tkRasRFP (acceptor) will
not only depend on their distance but also on the local acceptor
density that may vary as a function of time and space in a FLIM
time-lapse series. To account for this, the FRET rate (kT)p e r
acceptor density (kT/acceptor) that does not depend on the
concentration of acceptors in the plasma membrane [34] needs to
be determined. We estimated this parameter from the slopes of a
linear fit to the fluorescence rates (t
21)–acceptor intensity (Iaccep)
2D-histograms of the confocal images at selected time points
(Figure 5C). Ephrin-A5 stimulation of EphA3 resulted in a
significant decrease in kT/acceptor values (Figure 5C), indicating
an increased GFP-RFP distance. The maximal decrease in the
kT/acceptor ratio was observed after 20 min stimulation and was
followed by partial recovery of the FRET efficiency to that seen
with inactive EphA3. By comparison, a confocal FLIM time series
of ephrin-A5 stimulated cells expressing constitutively active
EphA3[2YE]-GFP or inactive EphA3[3YF]-GFP, containing
Phe-replacements of all critical tyrosine residues (Figure 5D, 5E)
[16,27] yielded no significant change in the kT/acceptor slopes,
indicating that in this case stimulation does not notably change
the distance between GFP and RFP (Figure 5D, 5E). The lower
kT/acceptor value for EphA3[2YE]-GFP and the higher value for
EphA3[3YF]-GFP as compared to non-stimulated EphA3[wt]-
GFP are consistent with constitutively extended and constitutively
constrained conformations, respectively, of these receptor
mutants.
We note that single cell FLIM analysis of the Wt EphA3
conformation during stimulation exhibits considerable variance,
reflecting different mixtures of active and inactive receptor
populations at each spatially resolvable volume element in the
image. We therefore compared the constitutive conformations of
kinase active EphA3[2YE]-GFP with that of inactive EphA3[3YF]-
GFP. We computed cumulative 2D-histograms of fluorescencerates
versus acceptor intensities for the [2YE]-, [3YF]-, and [2YE-KM]-
mutants using fluorescence lifetime/acceptor intensity images of
cells for each of the mutant receptors (Figure 5F) obtained with
wide-field frequency-domain FLIM (Figure S9C [35]). The energy
transfer rate, kT/acceptor, was calculated from the slope of a linear
fit to the fluorescence rate—acceptor intensity 2D-histograms in
which the intercept was set to the measured fluorescence rate of the
donor (GFP) in the absence of acceptor. The EphA3[2YE]-GFP
mutant exhibited significantly (p=7 610
214) lower FRET efficien-
cies (as apparent from kT/acceptor, right panel, Figure 5F) than the
inactive EphA3[3YF]-GFP mutant, indicating its extension from
the plasma membrane and confirming the conformational change
of the Wt EphA3 ICD observed upon stimulation of live cells. The
FRET efficiency of EphA3[2YE-KM]-GFP was in between these
extremes, suggesting that kinase-dead Eph with a flexible JM
domain adopts an intermediate position between a fully extended
and constrained cytoplasmic domain, as previously suggested [27].
The FRET rate (kT) is proportional to the fourth power of the
distance between the donor chromophore and acceptor plane [34].
From the fourth power root of the ratio of kT/acceptor of
EphA3[3YF]-GFP and EphA3[2YE]-GFP (Figure 5F), we can thus
estimate that the C-terminus of relaxed ([2YE]) EphA3-GFP is
1.3660.06timesfurther awayfromthe plasmamembranethan that
of constrained ([3YF]) EphA3-GFP.
Electron Tomography of Quantum Dot (Qdot) Labelled
EphA3 Confirms Increased Span of the Active EphA3 ICD
To examine at increased resolution the change in the span
between the plasma membrane and the carboxy-terminus of the
latent and activated receptor, we used electron microscopy (EM) to
image the EphA3 C-terminus that had been labelled with
streptavidin-conjugated Qdots (SA-Qdots [36]). We achieved the
site-specific targeting with SA-Qdots by engineering onto the
EphA3 C-terminus a biotin acceptor peptide (AP), which can be
specifically biotinylated using the E. coli biotin ligase (BirA) [37].
We validated the feasibility of the approach by binding SA-
Qdots to an NH2-terminal AP-tagged and biotinylated EphA3
(APN-EphA3). Confocal microscopy revealed that SA-Qdot
staining of APN-EphA3 cells correlated with anti-EphA3 staining
and shifted to a cytoplasmic compartment upon ephrin-stimula-
tion (Figure 6A), suggesting intact endocytosis of Eph-signaling
clusters [13]. EM of these cells revealed Qdots at the outer cell
surface at discernible distances from the plasma membrane
(Figure 6B). Considering that a reasonably broad range of
estimates (17–29 nm) likely reflects flexibility of the AP-tag linker
region, this provides an apparent distance between Qdots and
plasma membrane of ,24 nm (Figure 6C).
In order to image the span of the EphA3 cytoplasmic domain
we analysed cells co-expressing a cytoplasmic form of BirA
together with EphA3, AP-tagged at the C-terminus (APC-EphA3).
Microinjection of SA-Qdots into APC-EphA3-expressing cells and
sectioning of non-permeabilised cells allowed EM of EphA3-
bound Qdots at the intact plasma membrane (Figure 6D). We used
electron tomography with alignment, reconstruction, and segmen-
tation of 3D images (Figure 6E) to estimate Qdot/membrane
determined by the ANOVA test for multiple comparisons. (C) Biochemical analysis of ephrin release: EphA3/L-selectin transfected HEK293T cells were
pre-treated with CaM inhibitors (as in (A), using 50 mM W7) or vehicle control and incubated with ephrin-A5-Fc coated beads. In parallel, EphA3[2YE-
KM]-expressing cells were incubated with ephrin-A5-Fc coated beads only. Ephrin-A5 recovered by EphA3-Fc pulldown was immunoblotted with a-
ephrin-A5 antibodies. Total lysates were probed for EphA3/L-selectin (Eph-Sel) expression with a-EphA3 antibodies (bottom). * indicates non-relevant
proteins recognised by a-EphA3 antibodies in total lysates.
doi:10.1371/journal.pbio.1000215.g004
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PLoS Biology | www.plosbiology.org 8 October 2009 | Volume 7 | Issue 10 | e1000215Figure 5. FLIM analysis shows EphA3 activation accompanies extension of the cytoplasmic domain. (A) Schematic of the FRET-assay;
FRET (yellow arrow) reflects the proximity between the GFP on the EphA3 C-terminus and
tkRasRFP on the inner plasma membrane (Kin, kinase
domain). (B) Confocal FLIM time-series of EphA3-GFP in
tkRasRFP co-transfected COS7 cells at indicated times (min) after ephrin-A5 stimulation. Upper
row: EphA3-GFP fluorescence intensity images. Middle row:
tkRasRFP fluorescence intensity images. Lower row: fluorescence lifetime images of EphA3-
GFP; the colour bar inset indicates the fluorescence lifetime range in ns. (C) Upper panel: 2D-histograms of fluorescence rate t
21 versus
tkRasRFP
acceptor intensities for 0 min (red) and 20 min (blue) of the EphA3-GFP confocal FLIM series. Linear fitting of the time series 2D-histograms are
indicated by solid lines. Lower panel: acceptor normalized energy transfer rate, kT/acceptor, for selected time points after EphA3 stimulation as
derived from the slope of the fits to the 2D-histograms. (D) Upper panel: 2D-histograms of t
21 tkRasRFP acceptor intensities for 0 min (red) and 20 min
(blue) of a 2YE-EphA3-GFP confocal FLIM time series after ephrin-A5 stimulation (see also Figure S6F). Lower panel: acceptor normalized energy
transfer rate, kT/acceptor, of the time series as in (C). (E) Upper panel: 2D-histograms of t
21 tkRasRFP acceptor intensities for 0 min (red) and 20 min
(blue) of a 3YF-EphA3-GFP confocal FLIM time series after ephrin-A5 stimulation. Lower panel: acceptor normalized energy transfer rate, kT/acceptor,
of the time series as in (C). (F) Left panel: 2D-histograms of fluorescence rate, t
21, versus acceptor intensities for EphA3 [2YE], [3YF], and [2YE-KM]
obtained from at least 16 fluorescence lifetime/acceptor intensity images obtained with wide-field frequency-domain FLIM. Right panel: linear fitting
of these data showed a significant difference between the slopes (kT/acceptor) for EphA3-GFP-[2YE] and EphA3-GFP-[3YF].
doi:10.1371/journal.pbio.1000215.g005
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PLoS Biology | www.plosbiology.org 9 October 2009 | Volume 7 | Issue 10 | e1000215Figure 6. EM of Qdot labelled EphA3 reveals the molecular span to the plasma membrane. (A) Confocal microscopic images of APN
EphA3/HEK293T cells, biotinylated with recombinant biotin ligase (BirA) and labelled with SA-Qdots
605. Cells were left non-stimulated (top and
middle panel) or ephrin stimulated (bottom panel). To show the specificity of binding of the SA-Qdots to EphA3, samples were co-stained with an
EphA3-specific monoclonal antibody. Qdot staining is shown in red in the merged images. (B) EM image of biotinylated APN EphA3/HEK293T cells
labelled with SA-Qdots
605. Arrowheads mark EphA3-tethered Qdots on the outer cell membrane; insert: enlarged section of the (red) boxed area. (C)
Histogram depicting distances between Qdots bound to the NH2terminus of EphA3 and the plasma membrane. Distances were measured from EM
images of biotinylated APN EphA3/HEK293T cells that were incubated with SA-Qdots
605 as shown in (B). (D) SA-Qdot
605 micro-injected cells
expressing APC-EphA3[2YE] and [3YF] as indicated. Each image represents a 10 nm thick computational slice after 3D reconstruction from EM
tomography. Arrow heads indicate Qdots. (E) 3D reconstruction of an entire tilt series of images of a cell expressing APC-EphA3[3YF] (plasma
membrane, blue; Qdots, yellow; and marked by red arrowheads). A corresponding movie is included as supporting information (Video S1). (F)
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these ranged from 8–18 nm, with an average span from the
membrane of approximately 12 nm (12.32+/23.1 nm, Figure 6F).
Expression of Wt EphA3 or of EphA3[2YE] rapidly leads to
perturbation of the plasma membrane due to EphA3 activation
and endocytosis (Figure S10) and prevented assignment of Qdot/
membrane distances with and without ephrin stimulation. To
allow comparison of data from EM tomography with our FRET
analysis, we therefore analysed APC-EphA3[2YE], representing
EphA3 with relaxed JM regions, while co-expressing the clathrin-
assembly protein AP180 to block endocytosis [38] of activated
receptors in these cells (Figure 6D, left panel). The distribution of
Qdot positions in these cells was clearly different to APC-
EphA3[3YF] cells, suggesting for activated EphA3[2YE] an
average span of approximately 19 nm (19.37+/23.8 nm,
Figure 6F), approximately 1.660.5 times wider than that of
inactive [3YF]EphA3. This relative distance increase is consistent
with that determined by FLIM (above) and confirms a notable
extension of the activated receptor away from the plasma
membrane.
Discussion
Intracellular regulation of ADAM sheddases is known to control
the release of transmembrane growth factor precursors and the
activation of corresponding growth factor receptors. It was
identified as a cause for EGF receptor transactivation almost a
decade ago [17,19]. However, the mechanism linking kinase and
sheddase activities has remained elusive since its inception. We have
now elucidated a previously unrecognized conformational switch
that is embedded in the cytoplasmic domains of Eph receptors and
ADAMs and controls ADAM-function and Eph signalling.
Furthermore, marking the EphA3 C-terminus with fluorescent
(GFP) and electron-dense (Qdots) tags allowed for the first time to
demonstrate in live cells at molecular resolution that receptor
activation and tyrosine phosphorylation triggers a measurable shift
of the kinase domain away from the plasma membrane. The
increased span of activated EphA3 that we estimated by FLIM and
EM tomography is consistent with partial extension of the 64-
residue (G569 –N 633) receptor JM domain with a maximal
theoretical (b-sheet) span of ,20 nm. While it would seem
formally possible that extension of the activated EphA3 ICD
reflects an unfolding of the linker connecting the kinase with the
C-terminal SAM domain, recently elucidated crystal structures of
the EphA3 ICD argue against this possibility [28]: in the structures
of the active and of the inactive form, this C-terminal linker is
tethered to the base of the kinase, indicating that the C-terminal
part of the EphA3 cytoplasmic domain maintains a rigid, kinase-
associated configuration.
Together, our data suggest a model (Figure 7) where the
inactive, membrane-proximal receptor kinase domain obstructs
the productive alignment with ADAM10 that is necessary for
effective ephrin cleavage. This alignment of the ADAM and Eph
extracellular domains relies on a shift of the activated kinase
domain away from the membrane and on docking of the
ADAM10 substrate-recognition site to the high-affinity Eph/
ephrin complex [9]. Such a conformational switch provides rapid
and precise control of ADAM10-sheddase activity and challenges
the relevance of signalling intermediates that are thought to be
involved in the control of ADAM10 sheddase activity [4,5]:
N Our finding that cytoplasmic truncation of ADAM10 or of
EphA3 does not affect ephrin shedding confirms previous
studies revealing that phorbol ester-stimulated shedding by
ADAM17 is not effected by deletion of its cytoplasmic domain
[22].
N We further show that EphA3 JM mutations that permanently
raise the kinase domain close to the plasma membrane
significantly reduce ADAM10 association and ephrin shed-
ding, while mutations that cause constitutive extension
promote ephrin cleavage. This holds true irrespective of kinase
activity, as kinase-inactive but conformationally ‘‘relaxed’’
EphA3[2YE-KM] supports shedding, while EphA3[DJXS]
with an active but membrane-proximal kinase does not.
N Importantly, we demonstrate that inhibition of shedding by the
membrane-proximal Eph kinase domain occurs only with
intact ADAM10, but is effectively rescued with cytoplasmic-
truncated ADAM10 as sheddase: This indicates that it is
indeed the relief from a steric clash between the membrane-
proximal receptor domain and the ADAM10 cytoplasmic tail
that provides the molecular switch that allows productive
shedding to occur.
These findings have considerable implications for the under-
standing of Eph signalling: Currently it is established that contacts
between Eph and ephrin-expressing cells that fail to activate robust
Eph phosphorylation will lead to cell spreading and cell-cell
adhesion while cell-contact induced Eph activation and phospho-
tyrosine signalling result in cell rounding and cell segregation
[11,12,39]. Studies demonstrating the critical role of ADAM10-
catalysed ephrin shedding for cell repulsion revealed that
interaction with a cleavage-resistant ephrin mutant leads to
persisting Eph/ephrin contacts but does not prevent cell rounding
(axon collapse) [8], suggesting independent—but tightly synchro-
nised—processes during cell repulsion. They further imply that the
cell-biological consequence of an Eph/ephrin contact is deter-
mined only during assembly of the Eph/ephrin complex: Thus,
synchronisation of cell rounding and segregation requires a
molecular switch that rapidly relays the signalling competence of
the Eph kinase to the protease controlling ephrin shedding.
We now have elaborated the molecular mechanics of this relay in
whichkinase-active andkinase-inactiveEph receptorsadopt distinct
protein configurations that allow productive and unproductive
association with ADAM10, respectively. Previously, we demon-
strated that processed, catalytically active ADAM10 lacking the
inhibitory pro-domain [5] is associated with EphA3 also in the
absence of ephrin-A5 contact [9]. In the current context this implies
that ADAM10 is ‘‘on standby’’ to release Eph-bound ephrin from
interacting cells in the moment EphA3 becomes tyrosine-phos-
phorylated and adopts a conformation that allows ADAM10
alignment for optimal substrate access. Such a mechanism provides
for the synchronised Eph-triggered cell rounding and segregation
that is observed during cell-cell repulsion.
A host of stimuli that promote ADAM-mediated shedding,
including most prominently phorbol esters and calcium iono-
phores, have been described [5]. However, while interaction with
Histogram showing the cytoplasmic span of inactive versus active EphA3. Membrane-Qdot distances were measured in cells expressing biotinylated
APC-EphA3[3YF] (blue) or APC-EphA3[2YE] (red) that had been labelled with micro-injected SA-Qdots
605. Qdot/plasma membrane distances are
plotted at 3 nm intervals (3YF, n=30; 2YE, n=37). Kolmogorov-Smirnov (KS) and t statistical tests suggested a highly significant (p,0.001) difference
between the two datasets.
doi:10.1371/journal.pbio.1000215.g006
Eph-Controlled Ephrin Shedding
PLoS Biology | www.plosbiology.org 11 October 2009 | Volume 7 | Issue 10 | e1000215signalling proteins, in particular via SH3-binding motifs, have
been postulated, it has remained unclear if and how the different
agents could modulate ADAM activity [4]. The concept of
regulation via cytosolic intermediates has been challenged in
particular by the finding that PMA (phorbol-12-myristate-13-
acetate) efficiently activates an ADAM17 mutant lacking the ICD
[22]. Furthermore, CaM inhibitor and calcium-ionophore-
induced shedding of EGFR-ligands by ADAM10 is retained
partially by a mutant lacking the ICD [40]. Our findings now
reveal an entirely novel concept of RTK/ADAM regulation
whereby the conformation of the cytoplasmic domain directly
regulates ADAM activity rather than involving intermediate
signalling proteins and kinase activity per se.
It is tempting to speculate that steric hindrance represents a
conserved mechanism for receptor-regulated ADAM activity.
Regulated L-selectin shedding provides an important example of
Figure 7. Model for activation-mediated release of the membrane-proximal Eph kinase domain promoting productive ADAM10
alignment and ephrin shedding. The (helical) JM segment (red) of the unligated Eph receptor is tethered to the small (N-terminal) lobe of the
kinase [24], keeping the kinase domain (green) in an inactive, membrane-proximal conformation. Ephrin binding, Eph clustering (for simplicity only
one Eph/ephrin pair is illustrated instead of a cluster), activation, and auto-phosphorylation result in release of the tyrosine-phosphorylated JM
segment into a dynamic disordered protein fold [25] that allows extension of the kinase domain and the Eph C-terminus away from the membrane.
ADAM10, constitutively associated with the receptor, can then bind a new site formed by the Eph/ephrin complex via the ADAM10 substrate
recognition motif, which in turn mediates the correct orientation of the protease domain for ephrin cleavage [7]. The stoichiometry of the ADAM10/
Eph/ephrin complex remains to be elaborated. Importantly, this productive alignment of ADAM10 and Eph RTK relies on a RTK configuration where
its kinase domain—exerting steric hindrance for ADAM10 association—is removed from the plasma membrane.
doi:10.1371/journal.pbio.1000215.g007
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mechanism, where CaM binding to the L-selectin ICD [21] and its
ensuing conformational change seem to hinder the ability of
ADAM17 to shed L-selectin. Notably, upon protein binding to its
target site, CaM changes from an elongated to a globular structure
[41] with very similar dimensions (4–5 nm diameter) to the RTK
kinase domain. Our observation that CaM-binding to an EphA3/
L-selectin chimeric receptor can also regulate ADAM10 cleavage
of ephrins would seem to confirm steric hindrance as a mechanism
regulating Eph-associated ADAM activity and to suggest this as a
more widely conserved concept of ADAM regulation. For
example, steric hindrance could also explain the regulation of
ADAM activity by other RTKs such as the EGFR, which binds
CaM within the JM region [31] and controls ADAM-facilitated
ligand shedding in an activation dependent manner [5]. Indeed,
EGFR signalling can be triggered in a metalloprotease-dependent
manner by CaM inhibitors [30], preventing CaM access to a
binding site within the EGFR JM region [31].
Interestingly, our data suggest that ephrin cleavage and its receptor-
mediated internalisation may be controlled separately, since EphA3
with ‘‘relaxed’’ JM but inactive kinase domain effectively supports
ephrin cleavage but is not internalised. While details of Eph
endocytosis mechanisms remain to be elaborated, this finding is
consistent with signalling-dependent RTK endocytosis potentially
involving the ubiquitin ligase Cbl [42]. Importantly, effective
internalisation of the EphA3 2YE mutant suggests that the JM
tyrosines may not be essential for this endocytic signalling mechanism.
Lastly, we have developed a novel imaging strategy, which
bridges the gap between structural and cell-biological imaging, to
provide functional information for individual proteins in whole
cells at molecular resolution, and which could have applications in
a wide range of cell-biological systems. Our integrated FLIM- and
EM-based analyses reveal that Eph RTK activation triggers, in
addition to tyrosine phosphorylation, a measurable extension of
the ICD towards the cytosol. The previously unforeseen functional
consequences of this conformational change for downstream Eph
signalling and the regulation of ADAM10 activity are likely to
have important implications for the understanding of ADAM-
regulated biological processes in development and disease.
Material and Methods
Expression Constructs
Inactive EphA3 was made by substitution of residue K653 to M
in EphA3-GFP [13]. Insertion into bovine ADAM10-HA [9] of a
KpnI restriction site at C698 and removal of the ICD (retaining the
C-terminal HA tag) yielded ADAMDcyto. For EphA3-L-selectin, a
NheI restriction site at EphA3 G565 together with annealed L-




serted, with a terminal stop codon. For EphA3-APN the AP-tag
[37] was inserted after the EphA3 signal sequence (after Gly20), and
forEphA3-APCtheAP-tagwasinsertedintoaXmaIsite engineered
into the EphA3 C-terminus (Val983).
Biochemical Analyses
Cleaved ephrin-A5 was extracted from pooled Protein-A
Sepharose-pre-cleared lysates and culture supernatants of cells
that had been treated with pre-clustered or non-clustered ephrin-
A5-Fc by using EphA3-Fc coupled to Protein-A-Sepharose. Pull-
downs were analysed by anti-ephrin-A5 immunoblot. Cleavage of
cell-surface ephrin-A5 was assayed in 1-h co-cultures of ephrin-
A5-expressing HEK293T cells and EphA3/L-selectin transfected
cells by extracting ephrin-A5 from cell lysates with EphA3-Fc
coated Protein-A Sepharose. Where indicated, cells were treated
prior to ephrin-A5-stimulation with CaM inhibitors trifluopera-
zine, calmidazolium (Calm), or W7, or metalloprotase inhibitors
TAPI1 or GM6001 (Calbiochem). For CaM-co-precipitation
EphA3/L-selectin and Wt EphA3 tagged with a biotin AP were
biotinylated with BirA [37] and recovered on SA dynabeads.
Other co-immunoprecipitation experiments were performed
as indicated with anti-ADAM10 mAb (R&D Systems), anti-
ADAM10 polyclonal Ab39177 (Abcam), with anti-EphA3 mAb
IIIA4 [9] pre-coupled to mini-leak
TM agarose (Kem-En-Tec,
Copenhagen), and with anti-phosphotyrosine Sepharose (4G10,
Upstate Biotechnology). Transient expression of all EphA3
constructs was optimised by transfecting each at four cDNA
concentrations and selecting samples with similar expression levels
by Western blotting total lysates. Western blotting was performed
with antibodies against ephrin-A5 (R&D systems), EphA3 [43],
HA (3F10, Roche), ADAM10 (Biogenesis and Abcam Ab39177),
phosphotyrosine (4G10, Upstate Biotechnology), and CaM
(Upstate Biotechnology).
Confocal Microscopy
3-channel confocal microscopy was performed by sequential
scanning on Olympus FV1000 or Leica SP5 confocal microscopes.
Quantitation of internalised ephrin-A5-associated fluorescence
was achieved using ImageJ or Metamorph image analysis software
by selecting regions of cells to exclude bead-associated fluores-
cence. Microscopic evaluation of ephrin cleavage by EphA3/L-
selectin expressing cells, where ephrin-A5 was not internalised but
remained complexed at the plasma membrane, was done by
estimating the level of Alexa
488-ephrin labelling relative to the
expression level of the Alexa
647IIIA4 anti-EphA3 antibody-stained
receptor [15] on cell membranes (Figure 4B). Interactions between
cell-surface ephrin-A5 and EphA3/L-selectin were analysed using
ephrin-A5-GFP transfected cells [9].
FLIM
Time-domain confocal FLIM was performed in transiently
transfected Cos7 cells grown on coverslips or glass bottom dishes
(MatTek Corp.). FLIM images were obtained using an Olympus
Fluoview 1000 microscope, equipped with a Picoharp 300 photon
counting setup (Picoquant, Germany). GFP was excited with a
470 nm diode (Sepia II, Picoquant, Germany). Images of 5126512
pixels were acquired detecting approximately 10
8 photons. Images
of the donor fluorescence decays were processed using the
SymPhoTimesoftwarepackage(v4.2,Picoquant) and thecalculated
average fluorescence lifetime (t) images are presented in pseudo-
colour. The average fluorescence lifetime t(xy) images were
calculated from the parameters (a1,a2,t1,t2) of a double exponential
fit of the fluorescence decay curves [F(x,y,t)] in each pixel:
Fx ,y,t ðÞ ~a1 x,y ðÞ
{t
t1 x,y ðÞ za2 x,y ðÞ
{t
t2 x,y ðÞ ð1:1Þ





21-acceptor intensity (Ia) 2D-histograms were computed from the
confocal FLIM images as described below for wide-field frequency-
domain FLIM except that a bin size of 100 counts was used for the
acceptor intensity.
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IX70 inverted microscope (Olympus, Japan) equipped with a 100/
1.4 NA oil immersion lens, a 476 nm argon laser and narrow-band
emission filter (HQ510/20; Chroma) for GFP, a 100-W mercury
arc lamp with high Q Cy3 filter set (excitation filter, HQ545/30;
dichroic, Q580LP; emission filter, HQ610/75) for RFP, and a
dichroic beamsplitter (Q495 LP; Chroma Technology, Brattle-
boro, VT) and narrow-band emission filter.
Raw FLIM data were processed in IPLab (Scanalytics, Fairfax, VA,
USA) to generate a binary mask for the intensity threshold operation
data and a maskforthe ROI used inbackground correction ofthe raw
data. Using the raw FLIM data and mask, phase- and modulation
lifetime images were generated using scripts written in Python
programming language (http://www.python.org) with the Numarray
extension for numerical computing (http://www.stsci.edu/resources/
software_hardware/numarray) further augmented with low-level
routines written in C [44,45]. A cumulative 2D-histogram of
fluorescence lifetime (t) versus acceptor intensity (Ia) was generated
f r o mt h em u l t i p l ef l u o r e s c e n c ep h a s e - l i f e t i m ei m a g e s( $16 images)
and corresponding acceptor intensity images using a bin size of 320
intensity units (arbitrary units). The standard error in the fluorescence
lifetimes for each bin was calculated from the averages of all the
images. The donor to acceptor energy transfer rate kT normalized to
acceptor density (kT/acceptor) was obtained from the slope of a linear
fit to the t
212Ia (acceptor intensity) 2D-histograms. The t
212Ia 2D-








in which prior knowledge of the fluorescence lifetime in the absence of
acceptor (measured, td=1.96 ns) was used to constrain the intercept,
kd,t o0 . 5 1 .T h es l o p ek T/acceptor is proportional to
the energy transfer rate per acceptor yielding 1.9+/20.16 for
EphA3[3YF]-GFP, 0.56+/20.08 for EphA3[2YE]-GFP and 1.27+/
20.16 for EphA3[2YE-KM]-GFP. The relative distance increase
from GFP to the plasma membrane, comparing both conformations,














v u u u u u t ð1:4Þ
yielding a distance increase of GFP to the plasma membrane of
1.36+/20.06 for EphA3[2YE]-GFP relative to EphA3[3YF]-GFP.
EM
For EM we biotinylated AP-tagged EphA3 receptors in intact
cells using either exogenous or co-transfected biotin ligase (BirA)
[37], as indicated, before labelling with SA-Qdots
605 (Invitrogen).
Labelled cells were washed in PBS, fixed in 2.5% Glutaraldehyde,
2% sucrose for 40 min, and prepared on ice for EM by ‘‘epon’’
embedding: cells were rinsed in CaCo buffer (30 min), post-fixed
in 2% osmium tetroxide (40 min), washed (water), and stained
with 0.5% uranyl acetate (30 min). Fixed, washed cells were
dehydrated in graded ethanol solutions, embedded in epon 812
(Serva), and hardened (48 h) at 60uC. Epoxy-embedded blocks
were cut into 50 or 250 nm sections (Leica Ultracut S microtome)
and mounted on Formvar coated grids. Grids were post-stained
with led-citrate (1 min) at room temperature, rinsed with water,
and air dried. APC-EphA3 expressing cells, stably co-expressing
APc-EphA3 together with a cytoplasmic form of BirA for efficient
biotinylation of the AP-tagged EphA3 C-terminus, were either
microinjected with Qdots prior to fixation (where indicated) or
were fixed in 4% PFA, 0.5% Glutaraldehyde, 2% sucrose
(30 min), permeabilised with 0.1% Triton 6100, and incubated
with SA-Qdots
605 for 1 h. Washed samples were then fixed in
2.5% Glutaraldehyde, 2% sucrose, and prepared for EM as
described above. This approach partially solubilises the plasma
membrane and required computer-assisted assignment of the exact
plasma membrane/cytoplasm boundaries.
Electron Tomography
We collected at room temperature single-axis tilt series of
chemically fixed cells at 1–2u angular increment between 267u to
+67u using CM200 and Tecnai 30 microscopes (FEI, Eindhoven,
The Netherlands) and the Tietz tomography interface (Tietz,
Gauting, Germany) for data acquisition. Serial EM images were
recorded on 2 k62 k and 4 k64 k pixel CCD cameras at a
defocus level of 22 mm, with a pixel size at the specimen level of
0.7 nm. We aligned the projection images of the samples using
cross-correlation techniques. The merit figure of the aligned tilt-
series had a value of approximately 1 nm, indicating no
significant shrinkage of the sample. Reconstructions were
performed [46] using weighted back-projection algorithms and
visualized with isosurface and volume-rendering techniques in the
Amira software package (Mercury Computer Systems, San
Diego, CA, USA, www.amiravis.com). We de-noised three-
dimensional images with nonlinear anisotropic diffusion and
semi-automatically segmented those using erosion and dilation
operations after roughly segmenting regions of the reconstruc-
tions manually. Plasma membranes localisation in the electronic
images was semi-automated, with their boundaries determined
using dilation and erosion operations. Qdot detection was fully
automated according to their size and contrast using thresholding
techniques [46].
Supporting Information
Figure S1 Tyrosine phosphorylation and ADAM10 as-
sociation of EphA3 mutants. (A) Phosphorylation of Wt and
mutant EphA3 after incubation with clustered ephrinA5 Fc.
HEK293T cell clones stably expressing either Wt or kinase
inactive EphA3[K653M], or parental HEK293T cells, were
incubated with vehicle control (2), with non-clustered (NC) or
clustered (C) ephrinA5-Fc for 15 min prior to lysis. EphA3
immuno-precipitates were analysed by Western blot with anti-
phosphotyrosine (a-PY) and lysates with anti-EphA3 antibodies as
indicated. (B) The EphA3/ADAM10 association does not require
their ICDs. a-HA immunoprecipitates from cells expressing HA-
ADAM10, and/or Wt EphA3 or EphA3[DICD], were immuno-
blotted for EphA3 (top) or ADAM10 (bottom); total lysates were
probed for EphA3 (right). (U), unprocessed; (P), processed
ADAM10. Single exposures of blots are shown with non-relevant
lanes removed.
Found at: doi:10.1371/journal.pbio.1000215.s001 (0.64 MB TIF)
Figure S2 Inhibition of EphA3DICD-dependent ephrin
cleavage by metalloprotease inhibitors. Cells transiently
expressing EphA3[DICD] were incubated 1 h with the metallo-
protease inhibitor GM6001 (10 and 20 mM) or the ADAM-specific
inhibitor TAPI1 (50 mM) prior to incubation with Alexa
594-
ephrin-A5-coated beads. After 40 min the cells were placed on ice,
stained with anti-EphA3 (IIIA4)-Alexa
647, fixed and imaged by
confocal microscopy.
Found at: doi:10.1371/journal.pbio.1000215.s002 (4.45 MB
DOC)
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capacity of EphA3 mutants. HEK293T cells were transfected
with Wt or mutant EphA3-GFP constructs as indicated and
analysed for cell surface EphA3 expression by labelling with
Alexa
647-conjugated IIIA4 anti-EphA3 antibody specific for the
native EphA3 conformation [13] and with Alexa
594-conjugated
ephrinA5-Fc (ephrinA5-Alexa
594). Flow cytometric analysis shows
cell surface receptor expression (a-EphA3-Alexa
647) relative to
overall expression level (GFP) and to the ability of cells to bind
ephrin-A5-Alexa
594. The fraction of GFP-tagged EphA3 protein
on the cell surface was estimated as fraction of GFP-tagged
receptor recognised by the anti-EphA3 antibody: all EphA3 ICD
mutants are expressed at the plasma membrane and bind the
IIIA4 antibody and ephrin-A5 at levels similar to the Wt
receptor.
Found at: doi:10.1371/journal.pbio.1000215.s003 (0.96 MB TIF)
Figure S4 Phosphotyrosine profile and ADAM10 bind-
ing capacity of EphA3 JM mutants. (A) Phosphotyrosine
profile in cells transfected transiently to express Wt EphA3 and
JM mutants. HEK293T cells were transfected with expression
constructs for Wt EphA3-GFP or derived mutants, as indicated,
and cells treated with non-clustered or pre-clustered ephrin-A5 Fc
for 10 min. Anti-phosphotyrosine (PY) antibody (4G10) immuno-
precipitates from whole cell lysates were probed with anti-PY,
and total lysates with anti-EphA3 antibodies, as indicated.
Positions on the Western blot corresponding to molecular weights
of GFP-EphA3 and IgG (heavy and light chains) are indicated on
the left. Phosphorylated protein bands at the GFP-EphA3
position in the left panel are likely due to auto-phosphorylation
due to high transient over-expression of the EphA3 constructs in
these samples. (B) ADAM10 association with Wt and mutant
EphA3. ADAM10 immunoprecipitates and total cell lysates from
Wt or mutant (as indicated) EphA3-transfected cells (ephrin-A5-
treated) were analysed for EphA3 and ADAM10 by immunoblot.
Single exposures of blots are shown with non-relevant lanes
removed.
Found at: doi:10.1371/journal.pbio.1000215.s004 (1.02 MB TIF)
Figure S5 The extended (active) EphA3 ICD conforma-
tion is sufficient for ephrin cleavage, while internalisa-
tion requires an intact kinase. (A) Cells expressing Wt
EphA3-GFP, EphA3[2YE]-GFP, or kinase-inactive EphA3[2YE
KM]-GFP were incubated with Alexa
594ephrinA5-coated beads or
(B) pre-clustered, soluble Alexa
594ephrinA5. EphA3-GFP (green)
and Alexa
594ephrin (red) fluorescence in fixed cells was imaged by
confocal microscopy. Individual micrographs from fluorescent
channels, the merged images, and phase-contrast images are
shown. Yellow arrow heads denote areas of sustained interactions
between cell surface EphA3 and ephrin-A5 beads. White arrows
mark cell-membrane areas with bound- but not internalised
Alexa
594ephrin.
Found at: doi:10.1371/journal.pbio.1000215.s005 (2.71 MB TIF)
Figure S6 Removal of the ADAM10 ICD reconstitutes
ephrin shedding in cells expressing EphA3 JX mutants.
(A) Confirmation that ADAM102/2 MEFs do not contain
detectable ADAM10. Lysates of HEK293Ts, ADAM102/2,o r
Wt MEFs were immunoprecipitated with 1, protein A beads alone;
or with 2, anti-human specific ADAM10 monoclonal antibodies
(RND); or 3, with anti-ADAM10 polyclonal antibodies (Abcam).
Immunoprecipitates were immuno-blotted with polyclonal anti-
ADAM10 antibodies. U, unprocessed; P, processed ADAM10. (B)
ADAM102/2 MEFs transfected with combinations of GFP-
tagged EphA3 (Wt, DJXS, or DJXL) and HA-tagged ADAM10
(Wt, DMP, or DICD) were incubated with Alexa
594ephrinA5-
coated beads. After 40 min the cells were fixed, permeabilised, and
stained with anti-HA and Alexa
647-labelled secondary antibodies.
Images show single-section confocal micrographs, together with




Found at: doi:10.1371/journal.pbio.1000215.s006 (4.57 MB TIF)
Figure S7 CaM inhibitors regulate association of
EphA3-L-selectin with CaM and with ADAM10 and
trigger ephrinA5 shedding by EphA3-L-selectin express-
ing cells. (A) CaM inhibitors block association of CaM with
EphA3-L-selectin. Cells expressing AP-tagged EphA3/L-selectin
or Wt AP-EphA3 were treated with CaM inhibitors trifluoper-
azine (TFP) or Calm or vehicle control, as indicated. Following
biotinylation of AP-tagged receptors, EphA3 complexes were
recovered by SA pulldown and analysed by Western blot with
anti-CaM and anti-EphA3 antibodies. The positions of Wt
EphA3 and of the EphA3/L-selectin fusion protein are indicated.
(B) CaMinhibitorsmodulatetheassociationof EphA3/L-selectin
with ADAM10. HEK293T cells expressing EphA3/L-selectin
(left panels) or Wt EphA3 (right panels) were pre-treated (30 min)
with CaM inhibitors TFP (20 mM), Calm (2 mM), N-6-Amino-
hexyl0-5-chloro-1-naphthalenesulfonamide (W7, 100 mM), or
vehicle control before lysis. ADAM10 immunoprecipitates were
analysed by Western blot with anti-EphA3 or anti-ADAM10
antibodies, and total lysates with anti-EphA3 antibodies, as
indicated. The graph shows amounts of EphA3/L-selectin (left
panels) or EphA3 (right panels) in ADAM10 immunoprecipitates
relative to control lanes as determined by densitometry. (C)
Mutation of the CaM-binding site in EphA3-L-selectin reduces
its ability to support ephrinA5 cleavage. L358E and K359E
substitutions, reported to affect CaM binding to the L selectin
cytoplasmic domain, were introduced into the EphA3/L selectin
chimera to produce EphLsel EE. HEK293T cells, transfected
with Wt EphA3-L-selectin or with EphLsel EE were incubated
with Alexa
594-labelled ephrinA5 beads; the capacity to promote
ephrin cleavage was monitored by measuring ephrin labelling of
the cell membrane. Ephrin labelling relative to receptor
expression was determined in 50 regions from five individual
micrographs for each sample. The mean+/2SEM are shown in
the graph.
Found at: doi:10.1371/journal.pbio.1000215.s007 (1.48 MB TIF)
Figure S8 CaM-binding to chimeric EphA3/L-selectin
regulates ephrin cleavage from cells. (A) Microscopic
analysis of cleavage of GFP-ephrinA5 from cells. EphA3/
L-selectin transfected HEK293T cells were pre-treated (15 min)
with CaM inhibitors trifluoperazine (TFP, 15 mM), Calm (2 mM),
W7 (50 mM), or vehicle control before incubation (1 h) with cells
expressing GFP-ephrinA5. Cell surface EphA3/L-selectin
(Alexa
647 a-EphA3 antibody, red) and GFP-ephrinA5 (green)
were imaged in fixed cells by confocal microscopy, micrographs
from individual green and red fluorescence channels, and merged
images are shown. The outline of GFP-ephrin-A5 expressing cells
is indicated (….) for clarity. The open arrow head points at the
interface between untreated, EphA3/L-selectin, and GFP-
ephrinA5 cells. Yellow arrowheads indicate areas on CaM-
inhibitor-treated EphA3/L-selectin cells that are not in direct
contact with GFP-ephrin-A5 expressing cells but reveal obvious
ephrin staining. (B) Biochemical analysis of GFP-ephrinA5
cleavage from cells. EphA3/L-selectin transfected HEK293T cells
were pre-treated as in (A) with TFP, Calm, or vehicle control, then
incubated for 1 h with stably transfected ephrinA5/HEK293T
cells. Ephrin-A5 was recovered from cell lysates by pulldown with
EphA3-Fc beads and detected on Western blot with a-ephrinA5
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lysates were also probed for EphA3/L-selectin expression with
a-EphA3 antibodies (bottom). Cleaved ephrin-A5 was quantitated
by densitometry.
Found at: doi:10.1371/journal.pbio.1000215.s008 (2.57 MB TIF)
Figure S9 FLIM analysis of the EphA3-ICD reveals
extension of the activated EphA3 transmembrane do-
main. (A) Wide field frequency domain FLIM time-series of
EphA3-GFP (green) and
tkRasRFP (red) co-transfected COS7 cells
at indicated times (min) after ephrin-A5 stimulation. Upper row:
EphA3-GFP fluorescence intensity images. Lower row: fluores-
cence phase lifetime (tQ) images of EphA3-GFP colour bar inset
indicates the fluorescence lifetime range in ns. Lower image:
tkRasRFP fluorescence intensity image. (B) Histograms of GFP
phase lifetimes tW calculated on a pixel-by-pixel basis for the cells
displayed in (A). (C) Example of GFP phase (tW) and modulation
(tM) fluorescence lifetime images obtained by FLIM to generate
t
1-acceptor 2D-histograms (Figure 5F) of
tkRasRFP-COS7 cells co-
expressing Wt, [2YE], [2YE KM], or [3YF] EphA3-GFP. Strong
(cytosolic) EphA3 GFP fluorescence was blacked out to exclude
areas where the detector was saturated. Cumulative (2D) phase
(tW) and modulation (tM) fluorescence lifetime histograms of cell
populations (right panels) indicate significant fluorescence lifetime
differences between EphA3-GFP-[2YE] and EphA3-GFP-[3YF].
(D) The Kolmogorov-Smirnov (KS) test was performed to assess if
fluorescence lifetimes of either EphA3-GFP [3YF] or EphA3-GFP
[2YE] measured in a large population of tkRasRFP-Cos7 cells are
distinct. A highly significant (p,0.001) difference between the two
datasets suggests a measurable change in the donor (EphA3-GFP)/
acceptor (RFP-labelled membrane) distance. The two datasets
were entered for the KS test at http://www.physics.csbsju.edu/
stats/KS-test.html. (E) Acceptor photobleaching confirms the
reliability of fluorescence lifetime imaging to detect FRET.
tkRasRFP-transfected (red) Cos7 cells co-expressing EphA3-GFP
[3YF] (green) were imaged by FLIM. The images were taken from
the same cell before (bottom row) and following (top row) RFP
(acceptor) photobleaching. Areas of the cell where the fluorescent
acceptor was photobleached show an increase in the GFP lifetime
of the donor compared to the nonbleached sample, confirming the
fidelity of lifetime imaging to detect FRET.
Found at: doi:10.1371/journal.pbio.1000215.s009 (2.47 MB TIF)
Figure S10 EM of Qdot-labelled EphA3. EM images of
fixed APC-EphA3-expressing HEK293T cells without pretreat-
ment (A) or following ephrin stimulation (B), showing plasma
membrane disruption and endocytosis, respectively. Cells were
fixed, permeabilized, and stained with SA-Qdots 605 prior to EM
plastic embedding. Inserts show an enlarged section of the boxed
(red) areas, using computer-assisted assignment to delineate the
exact plasma membrane/cytoplasm boundary. Arrowheads mark
EphA3-tethered Qdots on the inner cell membrane.
Found at: doi:10.1371/journal.pbio.1000215.s010 (1.01 MB TIF)
Video S1 EM tomographic reconstruction of Qdot-
labelled EphA3-bearing cell membrane. EM tomography
of a protrusion of APC-EphA3 [3YF]-transfected cells, where
Qdots label the EphA3 COOH-terminus. The movie shows an
iso-surface visualization of the 3D tomographic reconstruction
displayed in Figure 6E from any aspect (360u). The plasma
membrane is visualized in blue and Qdots are shown in dark
yellow.
Found at: doi:10.1371/journal.pbio.1000215.s011 (0.47 MB AVI)
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